Literature DB >> 12933958

Sydenham's chorea may be a risk factor for drug induced parkinsonism.

A L Teixeira, F Cardoso, D P Maia, M C Cunningham.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12933958      PMCID: PMC1738638          DOI: 10.1136/jnnp.74.9.1350-a

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


× No keyword cloud information.
  7 in total

1.  Psychosis following acute Sydenham's chorea.

Authors:  Antônio Lúcio Teixeira; Débora Palma Maia; Francisco Cardoso
Journal:  Eur Child Adolesc Psychiatry       Date:  2006-06-20       Impact factor: 4.785

2.  Striatal microinjection of Sydenham chorea antibodies: using a rat model to examine the dopamine hypothesis.

Authors:  Hilla Ben-Pazi; Ofer Sadan; Daniel Offen
Journal:  J Mol Neurosci       Date:  2011-06-07       Impact factor: 3.444

3.  An update on the treatment of Sydenham's chorea: the evidence for established and evolving interventions.

Authors:  Kathleen G Walker; Jo M Wilmshurst
Journal:  Ther Adv Neurol Disord       Date:  2010-09       Impact factor: 6.570

4.  Neuropsychological manifestations in children with Sydenham's chorea after adjunct intravenous immunoglobulin and standard treatment.

Authors:  Claire Gregorowski; Christine Lochner; Lindi Martin; Candice Simmons; Martin Kidd; Kathleen Walker; Jo M Wilmshurst; Soraya Seedat
Journal:  Metab Brain Dis       Date:  2015-05-19       Impact factor: 3.584

5.  Sydenham's Chorea.

Authors:  Francisco Cardoso
Journal:  Curr Treat Options Neurol       Date:  2008-05       Impact factor: 3.598

Review 6.  Treatment of Sydenham's Chorea: A Review of the Current Evidence.

Authors:  Shannon L Dean; Harvey S Singer
Journal:  Tremor Other Hyperkinet Mov (N Y)       Date:  2017-06-01

Review 7.  Autoimmune and Paraneoplastic Chorea: A Review of the Literature.

Authors:  Kevin Kyle; Yvette Bordelon; Nagagopal Venna; Jenny Linnoila
Journal:  Front Neurol       Date:  2022-03-18       Impact factor: 4.003

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.